Skip to main content

CASI Pharmaceuticals, Inc (DE)

CASIDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000895051

CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in CASI Pharmaceuticals, Inc (DE) as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
−5 vs. Q4 2021
Shares held
23.3M
−4.62M (−16.5%) vs. Q4 2021
Total value
$18.9M
−$3.46M (−15.5%) vs. Q4 2021
New holders
5
7 more added
Sold out
10
14 more reduced

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CASI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 45 institutions
Q1 2021: 86 institutionsQ2 2021: 69 institutionsQ3 2021: 59 institutionsQ4 2021: 51 institutionsQ1 2022: 45 institutionsQ2 2022: 24 institutionsQ3 2022: 24 institutionsQ4 2022: 23 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $18.9M
Q1 2021: $127.4MQ2 2021: $72.3MQ3 2021: $46.0MQ4 2021: $22.4MQ1 2022: $18.9MQ2 2022: $6.26MQ3 2022: $5.17MQ4 2022: $3.31MQ1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CASI and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 202223$3.31M
Q3 202224$5.17M
Q2 202224$6.26M
Q1 202245$18.9M
Q4 202151$22.4M
Q3 202159$46.0M
Q2 202169$72.3M
Q1 202186$127.4M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc (DE); share changes are against Q4 2021.

Institutions holding CASI in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Federated Hermes, Inc.10,150,000$8.22M0.02%00.0%Unchanged
Vanguard Group Inc3,061,331$2.48M0.00%−789,759−20.5%Reduced
Wellington Shields Capital Management, LLC2,132,547$1.73M0.19%−56,000−2.6%Reduced
Wellington Shields & Co., LLC1,453,190$1.18M0.39%+312,000+27.3%Added
Ikarian Capital, LLC1,320,155$1.07M0.32%+97,088+7.9%Added
BlackRock Inc.1,190,383$964.0K0.00%−8,579−0.7%Reduced
Geode Capital Management, LLC1,141,064$923.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP389,273$315.0K0.00%−141,791−26.7%Reduced
Franklin Resources Inc360,900$292.0K0.00%00.0%Unchanged
State Street Corp355,552$288.0K0.00%+23,410+7.0%Added
Northern Trust Corp295,067$239.0K0.00%−2,177−0.7%Reduced
Millennium Management LLC192,504$156.0K0.00%−189,206−49.6%Reduced
RBF Capital, LLC159,367$142.0K0.01%00.0%Unchanged
Renaissance Technologies LLC155,300$126.0K0.00%−1,302,770−89.3%Reduced
Citadel Advisors LLC152,713$124.0K0.00%+134,831+754.0%Added
Dimensional Fund Advisors LP132,099$107.0K0.00%00.0%Unchanged
Boothbay Fund Management, LLC116,862$95.0K0.00%00.0%Unchanged
Virtu Financial LLC112,777$91.0K0.01%+31,971+39.6%Added
Citigroup Inc73,117$59.0K0.00%+73,117New
Charles Schwab Investment Management Inc54,063$44.0K0.00%00.0%Unchanged
Sterneck Capital Management, LLC40,000$32.0K0.02%00.0%Unchanged
Roundview Capital LLC38,112$31.0K0.00%−84,341−68.9%Reduced
Bank of New York Mellon Corp36,437$29.0K0.00%00.0%Unchanged
Heritage Investors Management Corp28,703$23.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc24,468$20.0K0.00%−25,928−51.4%Reduced
Bailard, Inc.25,100$20.0K0.00%+25,100New
Morgan Stanley24,041$19.0K0.00%−21,622−47.4%Reduced
Jane Street Group, LLC21,432$17.0K0.00%−31,984−59.9%Reduced
Fragasso Group Inc.16,500$13.0K0.00%+16,500New
Manatuck Hill Partners, LLC15,090$12.0K0.00%+15,090New
HighTower Advisors, LLC13,574$11.0K0.00%+9+0.1%Added
Ameriprise Financial Inc10,000$8.00K0.00%00.0%Unchanged
Everett Harris & Co10,002$8.00K0.00%00.0%Unchanged
Victory Capital Management Inc14,830$6.00K0.00%−422−2.8%Reduced
Tower Research Capital LLC (TRC)2,091$2.00K0.00%−3,502−62.6%Reduced
Advisor Group Holdings, Inc.2,001$2.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA1,345$1.09K0.00%00.0%Unchanged
Wells Fargo & Company713$1.00K0.00%+3+0.4%Added
Captrust Financial Advisors1,500$1.00K0.00%00.0%Unchanged
Bank of America Corp264$00.00%−117,653−99.8%Reduced
JPMorgan Chase & Co258$00.00%00.0%Unchanged
Royal Bank of Canada181$00.00%00.0%Unchanged
Northwestern Mutual Wealth Management Co132$00.00%00.0%Unchanged
Selective Wealth Management, Inc.5$00.00%00.0%Unchanged
Joseph P. Lucia & Associates, LLC1$00.00%+1New
Jacobs Levy Equity Management, Inc0$00.00%−1,677,146−100.0%Sold out
Marshall Wace, LLP0$00.00%−300,508−100.0%Sold out
Anson Funds Management LP0$00.00%−267,507−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−88,667−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−83,200−100.0%Sold out
Two Sigma Investments, LP0$00.00%−63,400−100.0%Sold out
Atom Investors LP0$00.00%−33,891−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−27,606−100.0%Sold out
Ground Swell Capital, LLC0$00.00%−18,638−100.0%Sold out
UBS Group AG0$00.00%−16,983−100.0%Sold out
Mosaic Family Wealth, LLC––––Not filed